Gaithersburg biotech startup Neuraly has raised $36 million for its potential Alzheimer’s disease and Parkinson’s disease treatment, the company announced.
{iframe}https://thedailyrecord.com/2018/07/19/gaithersburg-biotech-company-raises-36-million/{/iframe}